On the public citation graph
5‐HT6 antagonists as potential treatment for cognitive dysfunction
0 signed · 195 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archneur.60.8.1119openalex-snapshot
Alzheimer Disease in the US Population
inferredcites →https://doi.org/10.1002/(sici)1098-2396(199607)23:3<164::aid-syn5>3.0.co;2-6openalex-snapshot
Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats
inferredcites →https://doi.org/10.1002/gps.929openalex-snapshot
Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder
inferredcites →https://doi.org/10.1002/syn.10097openalex-snapshot
5‐HT 6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [ 125 I]SB‐258585
inferredcites →https://doi.org/10.1002/syn.10288openalex-snapshot
5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex
inferredcites →https://doi.org/10.1006/bbrc.1993.1619openalex-snapshot
A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP Accumulation
inferredcites →https://doi.org/10.1007/s00213-003-1552-5openalex-snapshot
Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro�04-6790
inferredcites →https://doi.org/10.1007/s00213-003-1652-2openalex-snapshot
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
inferredcites →https://doi.org/10.1007/s00213-004-1794-xopenalex-snapshot
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists
inferredcites →https://doi.org/10.1007/s002130100840openalex-snapshot
5-HT 6 receptor antagonists enhance retention of a water maze task in the rat
inferredcites →https://doi.org/10.1007/s00702-004-0214-zopenalex-snapshot
CNS Targets for multi-functional drugs in the treatment of Alzheimer?s and Parkinson?s diseases
inferredcites →https://doi.org/10.1007/s11096-004-1731-4openalex-snapshot
Pharmacogenetics as a tool in the therapy of schizophrenia
inferredcites →https://doi.org/10.1016/0166-4328(96)00105-2openalex-snapshot
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides
inferredcites →https://doi.org/10.1016/0166-4328(96)00109-xopenalex-snapshot
Classification and nomenclature of 5-HT receptors: a comment on current issues
inferredcites →https://doi.org/10.1016/j.bmcl.2004.01.071openalex-snapshot
1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands
inferredcites →https://doi.org/10.1016/j.bmcl.2004.05.076openalex-snapshot
Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2004.09.003openalex-snapshot
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands
inferredcites →https://doi.org/10.1016/j.bmcl.2004.10.064openalex-snapshot
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/j.bmcl.2005.01.005openalex-snapshot
4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands
inferredcites →https://doi.org/10.1016/j.bmcl.2005.01.031openalex-snapshot
1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands
inferredcites →https://doi.org/10.1016/j.bmcl.2005.05.092openalex-snapshot
Interaction of chiral MS-245 analogs at h5-HT6 receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2005.06.107openalex-snapshot
Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/j.bmcl.2005.07.028openalex-snapshot
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/j.bmcl.2005.08.059openalex-snapshot
Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2006.04.094openalex-snapshot
Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2006.08.068openalex-snapshot
Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors
inferredcites →https://doi.org/10.1016/j.bmcl.2006.10.036openalex-snapshot
Studies towards the identification of a new generation of atypical antipsychotic agents
inferredcites →https://doi.org/10.1016/j.bmcl.2006.12.093openalex-snapshot
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/j.clinthera.2005.07.015openalex-snapshot
Treatment of cognitive dysfunction in schizophrenia
inferredcites →https://doi.org/10.1016/j.drudis.2006.02.004openalex-snapshot
Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents
inferredcites →https://doi.org/10.1016/j.ejphar.2006.09.049openalex-snapshot
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
inferredcites →https://doi.org/10.1016/j.euroneuro.2006.06.009openalex-snapshot
Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating
inferredcites →https://doi.org/10.1016/j.neuropharm.2004.03.012openalex-snapshot
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism
inferredcites →https://doi.org/10.1016/j.pbb.2004.03.017openalex-snapshot
Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245
inferredcites →https://doi.org/10.1016/j.pbb.2005.05.005openalex-snapshot
Oral administration of the 5-HT receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task
inferredcites →https://doi.org/10.1016/j.pharmthera.2005.05.001openalex-snapshot
5-HT6 receptors: a novel target for cognitive enhancement
inferredcites →https://doi.org/10.1016/j.pnpbp.2004.11.004openalex-snapshot
On the trail of a cognitive enhancer for the treatment of schizophrenia
inferredcites →https://doi.org/10.1016/s0006-8993(02)02360-0openalex-snapshot
The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist [125I]SB-258585
inferredcites →https://doi.org/10.1016/s0022-3565(25)10539-9openalex-snapshot
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.
inferredcites →https://doi.org/10.1016/s0022-3565(25)38596-4openalex-snapshot
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
inferredcites →https://doi.org/10.1016/s0026-895x(25)13616-xopenalex-snapshot
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
inferredcites →https://doi.org/10.1016/s0028-3908(01)00056-9openalex-snapshot
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
inferredcites →https://doi.org/10.1016/s0028-3908(01)00165-4openalex-snapshot
5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
inferredcites →https://doi.org/10.1016/s0031-6997(25)06783-3openalex-snapshot
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
inferredcites →https://doi.org/10.1016/s0091-3057(01)00742-0openalex-snapshot
Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist
inferredcites →https://doi.org/10.1016/s0165-7208(97)80018-9openalex-snapshot
The 5-HT5, 5-HT6 and 5-HT7 receptors
inferredcites →https://doi.org/10.1016/s0166-4328(00)00316-8openalex-snapshot
Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation
inferredcites →https://doi.org/10.1016/s0169-328x(01)00034-1openalex-snapshot
Distribution of 5-ht5A, 5-ht5B, 5-ht6 and 5-HT7 receptor mRNAs in the rat brain
inferredcites →https://doi.org/10.1016/s0169-328x(01)00090-0openalex-snapshot
Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop
inferredcites →https://doi.org/10.1016/s0223-5234(00)01209-5openalex-snapshot
5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides
inferredcites →https://doi.org/10.1016/s0361-9230(02)00967-xopenalex-snapshot
Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist
inferredcites →https://doi.org/10.1016/s0893-133x(01)00265-2openalex-snapshot
The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus
inferredcites →https://doi.org/10.1016/s0893-133x(01)00400-6openalex-snapshot
Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat
inferredcites →https://doi.org/10.1016/s0959-4388(00)00068-4openalex-snapshot
Schizophrenia and cognitive function
inferredcites →https://doi.org/10.1016/s0960-894x(00)00320-6openalex-snapshot
6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/s0960-894x(00)00453-4openalex-snapshot
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists
inferredcites →https://doi.org/10.1016/s0960-894x(00)00597-7openalex-snapshot
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
inferredcites →https://doi.org/10.1016/s0960-894x(01)00558-3openalex-snapshot
Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT6 receptor
inferredcites →https://doi.org/10.1016/s0960-894x(02)00172-5openalex-snapshot
Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists
inferredcites →https://doi.org/10.1016/s0960-894x(03)00612-7openalex-snapshot
N1-Benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates
inferredcites →https://doi.org/10.1016/s0969-6210(05)70720-7openalex-snapshot
US: PolyOne – plastic compounds
inferredcites →https://doi.org/10.1016/s1351-4210(05)70784-8openalex-snapshot
Cognis earns pearlescent cosmetic preparation patent
inferredcites →https://doi.org/10.1021/jm010943mopenalex-snapshot
N-Arylsulfonylindole Derivatives as Serotonin 5-HT6Receptor Ligands
inferredcites →https://doi.org/10.1021/jm021085copenalex-snapshot
Influence of the 5-HT6Receptor on Acetylcholine Release in the Cortex: Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a Potent and Selective 5-HT6Receptor Antagonist
inferredcites →https://doi.org/10.1021/jm030030nopenalex-snapshot
Higher-End Serotonin Receptors: 5-HT5, 5-HT6, and 5-HT7
inferredcites →https://doi.org/10.1021/jm049243iopenalex-snapshot
Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1H-indole Derivatives as Potent, Selective 5-HT6Receptor Agonists and Antagonists
inferredcites →https://doi.org/10.1021/jm049615nopenalex-snapshot
Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6Receptor Ligands
inferredcites →https://doi.org/10.1021/jm060469qopenalex-snapshot
Binding of Sulfonyl-Containing Arylalkylamines at Human 5-HT6Serotonin Receptors
inferredcites →https://doi.org/10.1021/jm980532eopenalex-snapshot
5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor Antagonist
inferredcites →https://doi.org/10.1021/jm990550bopenalex-snapshot
2-Substituted Tryptamines: Agents with Selectivity for 5-HT6Serotonin Receptors
inferredcites →https://doi.org/10.1038/nm0706-780openalex-snapshot
Alzheimer disease: progress or profit?
inferredcites →https://doi.org/10.1038/sj.bjp.0701851openalex-snapshot
Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors
inferredcites →https://doi.org/10.1038/sj.bjp.0702445openalex-snapshot
Investigation of stretching behaviour induced by the selective 5‐HT6 receptor antagonist, Ro 04–6790, in rats
inferredcites →https://doi.org/10.1038/sj.bjp.0703288openalex-snapshot
In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate
inferredcites →https://doi.org/10.1038/sj.bjp.0703457openalex-snapshot
Characterization of SB‐271046: A potent, selective and orally active 5‐HT6 receptor antagonist
inferredcites →https://doi.org/10.1038/sj.bjp.0703458openalex-snapshot
Characterization of [125I]‐SB‐258585 binding to human recombinant and native 5‐HT6 receptors in rat, pig and human brain tissue
inferredcites →https://doi.org/10.1038/sj.npp.1300332openalex-snapshot
The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats
inferredcites →https://doi.org/10.1046/j.1471-4159.1996.66010047.xopenalex-snapshot
Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor
inferredcites →https://doi.org/10.1111/j.1365-2710.2006.00784.xopenalex-snapshot
Treatment of psychosis: 30 years of progress
inferredcites →https://doi.org/10.1111/j.1749-6632.1998.tb10178.xopenalex-snapshot
The Putative 5‐ht6 Receptor: Localization and Function
inferredcites →https://doi.org/10.1111/j.1749-6632.1998.tb10201.xopenalex-snapshot
Central Distribution and Function of 5‐ht6 Receptor Subtype in the Rat Brain
inferredcites →https://doi.org/10.1124/mol.54.3.577openalex-snapshot
The 5-Hydroxytryptamine6 Receptor-Selective radioligand [3H]Ro 63–0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum
inferredcites →https://doi.org/10.1124/mol.64.6.1295openalex-snapshot
Differences in the Central Nervous System Distribution and Pharmacology of the Mouse 5-Hydroxytryptamine-6 Receptor Compared with Rat and Human Receptors Investigated by Radioligand Binding, Site-Directed Mutagenesis, and Molecular Modeling
inferredcites →https://doi.org/10.1126/science.1072994openalex-snapshot
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
inferredcites →https://doi.org/10.1139/jpn.0641openalex-snapshot
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy
inferredcites →https://doi.org/10.1146/annurev.med.57.121304.131442openalex-snapshot
Current Pharmacotherapy for Alzheimer's Disease
inferredcites →https://doi.org/10.1146/annurev.med.58.060904.084114openalex-snapshot
Schizophrenia: New Pathological Insights and Therapies
inferredcites →https://doi.org/10.1146/annurev.pharmtox.40.1.319openalex-snapshot
5-ht6 Receptors as Emerging Targets for Drug Discovery
inferredcites →https://doi.org/10.1146/annurev.pharmtox.43.100901.140248openalex-snapshot
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
inferredcites →https://doi.org/10.1176/appi.ajp.158.2.176openalex-snapshot
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
inferredcites →https://doi.org/10.1176/appi.ajp.159.6.1018openalex-snapshot
Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder
inferredcites →https://doi.org/10.1176/appi.ajp.161.6.985openalex-snapshot
Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol
inferredcites →https://doi.org/10.1176/appi.ajp.162.10.1888openalex-snapshot
Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial
inferredcites →https://doi.org/10.1177/0091270006288734openalex-snapshot
Pharmacology of Acetylcholinesterase Inhibitors andN‐methyl‐ d ‐aspartate Receptors for Combination Therapy in the Treatment of Alzheimer's Disease
inferredcites →https://doi.org/10.1177/0091270006288735openalex-snapshot
Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease
inferredcites →https://doi.org/10.1192/bjp.162.1.43openalex-snapshot
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
inferredcites →https://doi.org/10.1212/wnl.58.5.828openalex-snapshot
Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson’s disease
inferredcites →https://doi.org/10.1345/aph.18211openalex-snapshot
Cholinesterase Inhibitors: A Therapeutic Strategy for Alzheimer Disease
inferredcites →https://doi.org/10.1358/dof.2005.030.05.907630openalex-snapshot
Drug discovery targets: 5-HT6 receptor
inferredcites →https://doi.org/10.1517/13543776.12.4.513openalex-snapshot
Recent progress in 5-HT6receptor antagonists for the treatment of CNS diseases
inferredcites →https://doi.org/10.1517/13543784.11.4.457openalex-snapshot
Therapeutic potential of serotonin antagonists in depressive disorders
inferredcites →https://doi.org/10.1586/14737175.4.5.799openalex-snapshot
Utilizing combination therapy in the treatment of Alzheimer’s disease
inferredcites →https://doi.org/10.1586/14737175.7.3.281openalex-snapshot
Methods for treating cognitive deficits in schizophrenia
inferredcites →https://doi.org/10.17615/74zp-ze10openalex-snapshot
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
inferredcites →https://doi.org/10.2147/nedt.2006.2.2.121openalex-snapshot
Memantine combined with an acetyl cholinesterase inhibitor ? hope for the future?
inferredcites →https://doi.org/10.2165/00023210-200418130-00001openalex-snapshot
Combination Therapy in Alzheimer???s Disease
inferredcites →https://doi.org/10.2165/00115677-200412010-00005openalex-snapshot
Management of Mild to Moderate Alzheimer Disease
inferredcites →https://doi.org/10.2174/0929867053764644openalex-snapshot
Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?
inferredcites →https://doi.org/10.2174/1568026023393877openalex-snapshot
Memories are Made of This (Perhaps): A Review of Serotonin 5-HT6 Receptor Ligands and Their Biological Functions
inferredcites →https://doi.org/10.2174/156802606776743039openalex-snapshot
Approaches to Palliative Therapies for Alzheimers Disease
inferredcites →https://doi.org/10.7270/q2154fjqopenalex-snapshot
BindingDB Entry 4895: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
inferredcites →https://doi.org/10.7326/0003-4819-140-8-200404200-00010openalex-snapshot
Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
inferredcites →https://doi.org/10.7326/0003-4819-140-8-200404200-00047openalex-snapshot
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ange.201003837openalex-snapshot
Stereocontrolled Creation of All‐Carbon Quaternary Stereocenters by Organocatalytic Conjugate Addition of Oxindoles to Vinyl Sulfone
inferred← citeshttps://doi.org/10.1002/anie.201003837openalex-snapshot
Stereocontrolled Creation of All‐Carbon Quaternary Stereocenters by Organocatalytic Conjugate Addition of Oxindoles to Vinyl Sulfone
inferred← citeshttps://doi.org/10.1002/cmdc.201200396openalex-snapshot
Cyclopropyl‐tryptamine Analogues: Synthesis and Biological Evaluation as 5‐HT6 Receptor Ligands
inferred← citeshttps://doi.org/10.1002/dta.223openalex-snapshot
Microwave‐accelerated preparation and analytical characterization of 5‐ethoxy‐N,N‐dialkyl‐[α,α,β,β‐H4]‐ and [α,α,β,β‐D4]‐tryptamines
inferred← citeshttps://doi.org/10.1002/ejoc.201500575openalex-snapshot
Two‐Step Synthesis of Blue Luminescent (Pyrrol‐3‐yl)‐1H‐(aza)indazoles Based on a Three‐Component Coupling–Cyclocondensation Sequence
inferred← citeshttps://doi.org/10.1002/gps.2120openalex-snapshot
Current awareness in geriatric psychiatry
inferred← citeshttps://doi.org/10.1007/s11094-011-0672-1openalex-snapshot
Syntheses and radioligand activities of dimebon analogs
inferred← citeshttps://doi.org/10.1007/s11094-012-0779-zopenalex-snapshot
5-HT6 Receptor antagonists. I. Screening of the library of various heterocyclic compounds containing an alkylsulfonyl moiety
inferred← citeshttps://doi.org/10.1007/s11094-012-0794-0openalex-snapshot
Serotonin 5-HT6 receptor antagonists. II. Synthesis and structure—activity relationship of 3-arylsulfonyl-2-methylthiopyrazolo[1,5-a]pyrimidines with substituents containing an amine in the 6-position
inferred← citeshttps://doi.org/10.1007/s11094-013-0861-1openalex-snapshot
5-Ht6 Receptor Antagonists. V. Structure – Activity Relationship of (4-Phenylsulfonyloxazol-5-yl)amines
inferred← citeshttps://doi.org/10.1016/b978-0-12-384976-2.00001-0openalex-snapshot
5-HT6 Medicinal Chemistry
inferred← citeshttps://doi.org/10.1016/b978-0-12-385902-0.00002-4openalex-snapshot
5-HT6 Receptor Memory and Amnesia: Behavioral Pharmacology – Learning and Memory Processes
inferred← citeshttps://doi.org/10.1016/b978-0-12-408139-0.00002-xopenalex-snapshot
Neurotransmitters and Memory
inferred← citeshttps://doi.org/10.1016/bs.pbr.2021.01.031openalex-snapshot
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
inferred← citeshttps://doi.org/10.1016/j.bbr.2018.04.032openalex-snapshot
5-HT6 receptor agonist EMD386088 impairs behavioral flexibility and working memory
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.08.006openalex-snapshot
Indene-based frameworks targeting the 5-HT6 serotonin receptor: Ring constraint in indenylsulfonamides using cyclic amines and structurally abbreviated counterparts
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.05.051openalex-snapshot
Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.10.033openalex-snapshot
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.12.055openalex-snapshot
Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2012.02.020openalex-snapshot
Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmc.2013.05.051openalex-snapshot
Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group
inferred← citeshttps://doi.org/10.1016/j.bmc.2014.01.003openalex-snapshot
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT6 antagonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.04.108openalex-snapshot
Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.10.067openalex-snapshot
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT6 receptor ligands
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.01.073openalex-snapshot
3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT6 receptor modulators
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.03.110openalex-snapshot
Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.06.060openalex-snapshot
Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.11.001openalex-snapshot
Indole-3-piperazinyl derivatives: Novel chemical class of 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.11.050openalex-snapshot
Novel brain penetrant benzofuropiperidine 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.10.057openalex-snapshot
Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N1-arylsulfonyl indole derivatives as 5-HT6 receptor ligands
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.04.024openalex-snapshot
1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2023.129497openalex-snapshot
5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines
inferred← citeshttps://doi.org/10.1016/j.ejmech.2009.10.035openalex-snapshot
8-Sulfonyl-substituted tetrahydro-1 H -pyrido[4,3- b ]indoles as 5-HT 6 receptor antagonists
inferred← citeshttps://doi.org/10.1016/j.pbb.2010.12.021openalex-snapshot
5-HT6 pharmacology inconsistencies
inferred← citeshttps://doi.org/10.1016/j.pbb.2014.10.006openalex-snapshot
Ro 04-6790-induced cognitive enhancement: No effect in trace conditioning and novel object recognition procedures in adult male Wistar rats
inferred← citeshttps://doi.org/10.1016/j.tet.2009.11.080openalex-snapshot
One-pot synthesis of highly substituted indolines
inferred← citeshttps://doi.org/10.1016/j.tet.2010.11.094openalex-snapshot
One-pot synthesis of substituted indolines via a copper-catalyzed sequential multicomponent/C–N coupling reaction
inferred← citeshttps://doi.org/10.1016/j.tetlet.2014.03.095openalex-snapshot
Synthesis of oxygenated 2-methylindolines
inferred← citeshttps://doi.org/10.1016/s0079-6468(09)04805-xopenalex-snapshot
Advances in the Design of 5-HT6 Receptor Ligands with Therapeutic Potential
inferred← citeshttps://doi.org/10.1016/s1569-7339(10)70110-7openalex-snapshot
Functional Pharmacogenetics of Serotonin Receptors in Psychiatric Drug Action
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01662openalex-snapshot
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/jm1007177openalex-snapshot
Development of Molecular Probes for the Human 5-HT6 Receptor
inferred← citeshttps://doi.org/10.1021/jm1007825openalex-snapshot
5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists
inferred← citeshttps://doi.org/10.1021/jm200466ropenalex-snapshot
N′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features
inferred← citeshttps://doi.org/10.1021/jm201079gopenalex-snapshot
Synthesis and Structure–Activity Relationship (SAR) of (5,7-Disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as Potent Serotonin 5-HT6Receptor (5-HT6R) Antagonists
inferred← citeshttps://doi.org/10.1021/jm300955xopenalex-snapshot
Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT6Receptor Antagonists
inferred← citeshttps://doi.org/10.1021/jm401895uopenalex-snapshot
Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia
inferred← citeshttps://doi.org/10.1021/jm5003952openalex-snapshot
Serotonin 5-HT6Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1021/jm900796popenalex-snapshot
Identification of Novel Indanylsulfonamide Guanylhydrazones as Potent 5-HT6Serotonin Receptor Antagonists
inferred← citeshttps://doi.org/10.1021/jm901674fopenalex-snapshot
5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT6 Receptor Antagonists
inferred← citeshttps://doi.org/10.1021/ml100101uopenalex-snapshot
Novel and Potent 5-Piperazinyl Methyl-N1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands
inferred← citeshttps://doi.org/10.1039/c1md00202copenalex-snapshot
Potential atypical antipsychotics: synthesis, binding affinity and SAR of new heterocyclic bioisosteric butyrophenone analogues as multitarget ligands
inferred← citeshttps://doi.org/10.1039/c5cc04279hopenalex-snapshot
Phosphine-catalyzed [4+1] annulation of 2-tosylaminochalcones with allenoates: synthesis of trans-2,3-disubstitued indolines
inferred← citeshttps://doi.org/10.1039/c8ra03107jopenalex-snapshot
The effect of the intramolecular C–H⋯O interactions on the conformational preferences of bis-arylsulfones – 5-HT 6 receptor antagonists and beyond
inferred← citeshttps://doi.org/10.1039/d0cc05699eopenalex-snapshot
Synthesis of heterocyclic compounds through nucleophilic phosphine catalysis
inferred← citeshttps://doi.org/10.1070/rc2014v083n05abeh004371openalex-snapshot
Sulfonyl-containing modulators of serotonin 5-HT6receptors and their pharmacophore models
inferred← citeshttps://doi.org/10.1111/cbdd.12563openalex-snapshot
Combination of Pharmacophore Matching, 2D Similarity Search, andIn VitroBiological Assays in the Selection of Potential 5‐HT6Antagonists from Large Commercial Repositories
inferred← citeshttps://doi.org/10.1124/dmd.114.059675openalex-snapshot
Disposition and Metabolic Profiling of [14C]Cerlapirdine Using Accelerator Mass Spectrometry
inferred← citeshttps://doi.org/10.1124/mol.109.060103openalex-snapshot
A Novel Multilevel Statistical Method for the Study of the Relationships between Multireceptorial Binding Affinity Profiles and In Vivo Endpoints
inferred← citeshttps://doi.org/10.12688/f1000research.160416.1openalex-snapshot
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
inferred← citeshttps://doi.org/10.12688/f1000research.160416.2openalex-snapshot
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
inferred← citeshttps://doi.org/10.12688/f1000research.160416.3openalex-snapshot
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
inferred← citeshttps://doi.org/10.13005/bpj/3304openalex-snapshot
Pharmacophoric Determinants of 5-HT₂A Agonism: A Machine Learning–Based QSAR Study of Tryptamine Derivatives Using Random Forest for CNS Drug Design
inferred← citeshttps://doi.org/10.1515/revneuro-2013-0026openalex-snapshot
5-HT systems: emergent targets for memory formation and memory alterations
inferred← citeshttps://doi.org/10.1515/revneuro-2014-0001openalex-snapshot
Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative
inferred← citeshttps://doi.org/10.1515/tnsci-2016-0007openalex-snapshot
The serotonergic system and cognitive function
inferred← citeshttps://doi.org/10.1517/13543776.2012.709236openalex-snapshot
5HT6receptor antagonists: a patent update. Part 1. Sulfonyl derivatives
inferred← citeshttps://doi.org/10.2174/092986711796011283openalex-snapshot
Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
inferred← citeshttps://doi.org/10.2174/1874844901603010138openalex-snapshot
Design, Synthesis and Evaluation of Substituted 3-(1, 4-Diazepanyl)-Methyl-Phenyl-Sulphonamides as Potent 5-HT6 Antagonists in Cognitive Disorders
inferred← citeshttps://doi.org/10.3109/14756366.2010.510471openalex-snapshot
Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6receptor ligands
inferred← citeshttps://doi.org/10.3109/14756366.2014.889126openalex-snapshot
Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6receptor antagonists
inferred← citeshttps://doi.org/10.3109/14756366.2015.1103233openalex-snapshot
Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders
inferred← citeshttps://doi.org/10.3233/jad-2012-121186openalex-snapshot
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
inferred← citeshttps://doi.org/10.32383/farmpol/161474openalex-snapshot
The use of machine learning-based sequential virtual screening in the search of new ligands of 5-HT6 receptor
inferred← citeshttps://doi.org/10.3390/ijms20143420openalex-snapshot
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
inferred← citeshttps://doi.org/10.3390/ijms23169443openalex-snapshot
Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/molecules24244472openalex-snapshot
Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.